Fisher Asset Management, LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 242 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$30,587,401
-29.0%
303,296
-4.3%
0.02%
-29.2%
Q2 2023$43,081,886
+30.4%
317,035
-0.1%
0.02%
+20.0%
Q1 2023$33,029,433
+108424.5%
317,401
-7.6%
0.02%
-4.8%
Q4 2022$30,435
-99.9%
343,360
+14.0%
0.02%
+16.7%
Q3 2022$24,142,000
-15.1%
301,133
+1.4%
0.02%
-10.0%
Q2 2022$28,448,000
-37.1%
297,074
-2.4%
0.02%
-25.9%
Q1 2022$45,237,000
+2.6%
304,525
-2.1%
0.03%
+8.0%
Q4 2021$44,088,000
+7.8%
311,007
-0.5%
0.02%0.0%
Q3 2021$40,891,000
-7.5%
312,547
-2.9%
0.02%
-10.7%
Q2 2021$44,227,000
+9.5%
321,818
+4.1%
0.03%0.0%
Q1 2021$40,385,000
+13.3%
309,249
-2.8%
0.03%
+3.7%
Q4 2020$35,646,000
+45.0%
318,268
+1.9%
0.03%
+22.7%
Q3 2020$24,582,000
+6.7%
312,476
-2.4%
0.02%0.0%
Q2 2020$23,037,000
+28.1%
320,006
+1.9%
0.02%0.0%
Q1 2020$17,980,000
-45.4%
313,952
+6.6%
0.02%
-33.3%
Q4 2019$32,949,000
-6.1%
294,634
-19.3%
0.03%
-15.4%
Q3 2019$35,089,000
-19.3%
364,944
-28.1%
0.04%
-18.8%
Q2 2019$43,454,000
-45.8%
507,822
-53.6%
0.05%
-5.9%
Q1 2019$80,117,000
+115.4%
1,095,380
+89.1%
0.05%0.0%
Q4 2018$37,198,000
-16.8%
579,407
+2.6%
0.05%
-5.6%
Q3 2018$44,728,000
+4.1%
564,601
-3.8%
0.05%
-3.6%
Q2 2018$42,974,000
+11.4%
587,073
-3.6%
0.06%
+9.8%
Q1 2018$38,585,000
+22.9%
609,267
-1.1%
0.05%
+24.4%
Q4 2017$31,391,000
-3.3%
615,878
-0.4%
0.04%
-10.9%
Q3 2017$32,446,000
+6.3%
618,378
+3.2%
0.05%0.0%
Q2 2017$30,532,000
+16.7%
599,363
+1.8%
0.05%
+9.5%
Q1 2017$26,160,000
-6.3%
589,051
-6.9%
0.04%
-14.3%
Q4 2016$27,932,000
+10.1%
632,386
-0.2%
0.05%
+8.9%
Q3 2016$25,372,000
+16.5%
633,349
+43.5%
0.04%
+12.5%
Q2 2016$21,774,000
+29.9%
441,386
+14.3%
0.04%
+25.0%
Q1 2016$16,767,000
-1.6%
386,330
-0.1%
0.03%
-3.0%
Q4 2015$17,034,000
-8.0%
386,705
-0.3%
0.03%
-15.4%
Q3 2015$18,520,000
-18.8%
387,933
-0.9%
0.04%
-11.4%
Q2 2015$22,807,000
+14.8%
391,394
-0.5%
0.04%
+10.0%
Q1 2015$19,862,000
+8.9%
393,394
-3.0%
0.04%
+5.3%
Q4 2014$18,240,000
+19.6%
405,705
-2.0%
0.04%
+18.8%
Q3 2014$15,245,000
+413.1%
413,810
+514.9%
0.03%
+433.3%
Q2 2014$2,971,000
+1.6%
67,3000.0%0.01%
-14.3%
Q1 2014$2,924,000
-7.3%
67,300
-9.3%
0.01%0.0%
Q4 2013$3,154,000
+1.6%
74,200
-18.8%
0.01%
-12.5%
Q3 2013$3,104,000
+8.7%
91,4000.0%0.01%
+14.3%
Q2 2013$2,855,00091,4000.01%
Other shareholders
CONMED CORP shareholders Q3 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders